Disease Overview：In Vitro Fertilization and Embryo Transfer（IVF-ET）
In vitro fertilization–embryo transfer (IVF-ET) is an assisted reproductive technology (ART) used to treat infertility caused by diverse etiologies—including tubal factor infertility, male factor infertility, endometriosis, ovulatory disorders, unexplained infertility, and diminished ovarian reserve. The procedure involves ovarian stimulation, transvaginal oocyte retrieval, fertilization of oocytes with sperm in a controlled laboratory environment, embryo culture for 3–5 days, and subsequent transfer of one or more viable blastocysts into the uterine cavity. Preimplantation genetic testing (PGT-A/PGT-M) may be integrated to enhance implantation potential and reduce miscarriage risk. IVF-ET success rates are influenced by maternal age, embryo quality, endometrial receptivity, and clinic-specific protocols.
China offers compelling advantages for international patients seeking IVF-ET: its reproductive medicine centers—many accredited by the National Health Commission—employ board-certified reproductive endocrinologists and embryologists trained in evidence-based protocols. Advanced technologies such as time-lapse embryo imaging, vitrification-based cryopreservation, and AI-assisted embryo selection are widely adopted. Leading hospitals report clinical pregnancy rates of 60–70% per fresh blastocyst transfer in women under 35, supported by over two decades of cumulative case volume exceeding millions. Cost-effectiveness is notable: comprehensive IVF-ET cycles—including medications, PGT-A, and frozen embryo transfers—typically range from USD $8,000–$12,000, representing 40–60% savings versus comparable care in the US, UK, or Australia. As a dedicated medical tourism agency, we facilitate seamless access to top-tier fertility centers by coordinating hospital appointments, verifying clinician credentials, providing itemized, transparent pricing, and delivering end-to-end support—from visa assistance and accommodation to multilingual patient advocacy and post-treatment follow-up.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: In Vitro Fertilization–Embryo Transfer (IVF-ET)
Non-Surgical / Conservative / Medication Options
*Target criteria:* Female age <35, AFC ≥5, AMH ≥1.2 ng/mL, patent fallopian tubes, normal semen parameters (WHO 2021), no uterine cavity distortion.
- •Ovulation Induction + Timed Intercourse (OI-TI)
- Gonadotropin stimulation (7–10 days, rFSH 75–150 IU/day): $180–$320 - hCG trigger + timed intercourse guidance: $35 *Total per cycle: $260–$400*
- •Intrauterine Insemination (IUI) with Ovarian Stimulation
- Medication (clomiphene or gonadotropins): $120–$280 *Total per cycle: $510–$800*
Surgical / Procedural / Interventional Options
*Eligibility:* Failed ≥3 IUI cycles, severe male factor (total motile sperm <5 million), tubal occlusion, endometriosis Stage III/IV, or recurrent implantation failure.
- •Standard IVF-ET (Fresh Cycle)
- Controlled ovarian hyperstimulation (COH) + monitoring (6–8 ultrasounds + hormone assays): $620 - Egg retrieval (transvaginal US-guided, sedation included): $1,150 - Embryo culture (Day 3 or blastocyst), fertilization (conventional IVF or ICSI if indicated): $1,380 - Fresh embryo transfer + luteal support: $420 *Total per fresh cycle: $3,050–$3,270*
- •Frozen Embryo Transfer (FET) Cycle
- Frozen-thawed embryo transfer + transfer procedure: $490 *Total per FET cycle: $800*
Special / Complex Condition Options
- •Preimplantation Genetic Testing for Aneuploidy (PGT-A): $1,950 (includes biopsy, NGS sequencing, reporting)
- •Donor Egg IVF (with recipient prep + donor screening): $6,800–$8,200
- •Surrogacy coordination + legal documentation (non-medical, but clinically integrated): $1,400 (administrative fee only; excludes surrogate compensation)
Quick Selection Guide
- •Age <35, budget-conscious ($1,500–$3,000): Start with 2–3 IUI cycles ($510–$800 each); proceed to IVF if unsuccessful.
- •Age 35–39, moderate budget ($3,000–$5,000): Direct IVF-ET fresh cycle ($3,050–$3,270); add PGT-A only if recurrent loss or prior aneuploid pregnancy.
- •Age ≥40 or diminished ovarian reserve (AMH <0.8 ng/mL): Proceed directly to IVF with PGT-A ($5,000 total); consider donor eggs if ≥2 failed autologous cycles.
- •Severe male factor or recurrent implantation failure: Mandatory ICSI + ERA + PGT-A — total ~$5,200.
- •Comorbidities (PCOS, obesity BMI ≥30, thyroid autoimmunity): Require individualized COH protocols and extended luteal support — adds $120–$200 to base IVF cost.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended In Vitro Fertilization and Embryo Transfer Medical Vacation Packages
Curated transparent all-inclusive packages combining In Vitro Fertilization and Embryo Transfer treatment with China top medical destinations:
